MedPath
FDA Product

ANECTINE NOV

Product approved by U.S. Food and Drug Administration (US)

Basic Information

ANECTINE NOV

82650-139

Regulatory Information

82650-139

NDA008453

C73594

March 13, 2024

USA

These highlights do not include all the information needed to use ANECTINE safely and effectively. See full prescribing information for ANECTINE NOV. ANECTINE (succinylcholine chloride) injection, for intravenous or intramuscular use Initial U.S. Approval: 1952

HUMAN PRESCRIPTION DRUG LABEL

1

Company Information

242254227

Active Ingredients

SODIUM CHLORIDE

Code: 451W47IQ8X

Class Code: IACT

HYDROCHLORIC ACID

Code: QTT17582CB

Class Code: IACT

METHYLPARABEN

Quantity: 1 mg in 1 mL

Code: A2I8C7HI9T

Class Code: IACT

SODIUM HYDROXIDE

Code: 55X04QC32I

Class Code: IACT

SUCCINYLCHOLINE CHLORIDE

Quantity: 20 mg in 1 mL

Code: I9L0DDD30I

Class Code: ACTIB

Active Moieties

SUCCINYLCHOLINE

Code: J2R869A8YF

© Copyright 2025. All Rights Reserved by MedPath